BPC-157 + TB-500 (10mg)

BPC-157 + TB-500 is a two-compound research blend supplied as a lyophilised vial. This product is also called the Wolverine Stack. Its 10mg listed size refers to the combined blend, not 10mg of each compound. It is a separate product from the BPC-157-only and TB-500-only vials.

The Wolverine Stack is a common nickname for the combination of BPC-157 and TB-500. This listing supplies both compounds pre-blended in a single 10mg research vial. The nickname identifies the combination; it is not evidence of rapid healing or proof that the blend outperforms either ingredient alone.

The sample name on the BPC-157 + TB-500 laboratory report #71744 is “BPC5mg+TB5mg Blend”: 5mg of each compound, or 10mg combined, as the nominal amounts. Janoshik measured 5.76mg BPC-157 and 5.65mg TB-500 (TB4) in that sample on 18 July 2025, totalling 11.41mg. The nominal amounts identify the blend; the laboratory results describe the sample tested and do not verify every vial. The report’s batch field is marked unknown.

This 10mg blend combines nominally 5mg BPC-157 and 5mg TB-500 in one vial. The separate BPC-157 10mg and TB-500 10mg listings each supply one compound at a listed 10mg vial size. Those are different product quantities and formats. A single-compound vial allows that material to be assessed independently; a pre-blended vial contains both materials together. See each product’s own laboratory report when comparing sample amounts.

Combining the compounds gives a laboratory a pre-blended material containing both BPC-157 and TB-500. A study would need to compare that mixture with suitable controls and each ingredient separately to establish any combined effect. The fact that the ingredients have separate research literatures does not prove that mixing them improves performance.

For BPC-157, a study of BPC-157 in rat tendon cells and tissue explants investigated cell migration, survival under stress and tendon outgrowth. It did not test the BPC-157 + TB-500 blend or establish injury recovery in people. The public report labels the other component “TB-500 (TB4)” but does not publish an amino-acid sequence. Studies of full-length thymosin beta-4 should therefore not be treated as direct evidence for this exact product. The cited ingredient research does not show that this blend heals injuries or is superior to separate compounds.

This blend is supplied as a lyophilized powder and should be reconstituted with bacteriostatic water (BAC water) immediately before use. Inject the BAC water slowly into the vial, directing the stream down the inside wall. Gently swirl to dissolve — do not shake. Once reconstituted, store at 2–8°C and use within 8–12 weeks. For a full step-by-step walkthrough, see our complete peptide reconstitution guide.

Store lyophilized BPC-157 + TB-500 vials at -20°C, away from light and moisture. After reconstitution with BAC water, refrigerate at 2–8°C and use within 8–12 weeks. Do not freeze the reconstituted solution.

The BPC-157 + TB-500 10mg blend, also called the Wolverine Stack, is listed through Aussie Peptides for domestic delivery across Australia. Check the live availability before ordering and review the BPC-157 + TB-500 laboratory report #71744 for the measured component amounts in its tested sample.

BPC-157 + TB-500 (10mg) is currently in stock at Aussie Peptides and available for domestic dispatch across Australia. BPC-157 + TB-500 (10mg) is priced at $109.99 per vial at Aussie Peptides. All orders ship domestically within Australia, and batch CoAs are available in our CoA library.

When the BPC-157 + TB-500 (10mg) blend is in stock, add the vial to your cart and complete checkout on the Aussie Peptides website. Orders are fulfilled domestically with tracking across Australia. Review the composition and public laboratory report when selecting material for laboratory research.